HANNAH HALL: Open Payments
NPI 1922720630 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,645 in 106 payments from 19 companies in 2025. Trend: 2023 $1,503 · 2024 $2,578 · 2025 $2,645
Food & beverage: $2,645
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $463 |
| GENZYME CORPORATION | 14 | $454 |
| GlaxoSmithKline, LLC. | 25 | $325 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $288 |
| Regeneron Healthcare Solutions, Inc. | 8 | $252 |
| Merck Sharp & Dohme LLC | 9 | $235 |
| United Therapeutics Corporation | 4 | $121 |
| Insmed, Inc. | 4 | $97 |
| Actelion Pharmaceuticals US, Inc. | 3 | $74 |
| Amgen Inc. | 3 | $63 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, TRELEGY ELLIPTA, Arikayce, Tyvaso, OFEV, OPSUMIT.
Industry payments across TN — which companies pay providers there.
